OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
23
Results
Show all
Save search
Copy query
Show results for
Unknown
(23)
Publication Date
Release Date
2023
(7)
2021
(4)
2018
(4)
2020
(3)
2025
(1)
2022
(1)
2019
(1)
2016
(1)
2013
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Simvastatin in Critically Ill Patients with Covid-19.
Not available
S-EPMC10755839
|
biostudies-literature
Cite
Cell-type-specific DNA methylation dynamics in the prenatal and postnatal human cortex.
Not available
S-EPMC12802690
|
biostudies-literature
Cite
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
Not available
S-EPMC8362592
|
biostudies-literature
Cite
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
Not available
S-EPMC8362594
|
biostudies-literature
Cite
Autosomal Dominant STAT6 Gain of Function Causes Severe Atopy Associated with Lymphoma.
Not available
S-EPMC10499697
|
biostudies-literature
Cite
Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection.
Not available
S-EPMC5918692
|
biostudies-literature
Cite
2023 Canadian Surgery Forum: Sept. 20-23, 2023.
Not available
S-EPMC10718225
|
biostudies-literature
Cite
Practical challenges for functional validation of STAT1 gain of function genetic variants.
Not available
S-EPMC10128160
|
biostudies-literature
Cite
Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans.
Not available
S-EPMC6148345
|
biostudies-literature
Cite
Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations.
Not available
S-EPMC8246418
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets